Päivi Kannisto

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Emergency Medical

Cancer Stem Cells

Top Venues

Journal of multidisciplinary healthcare

Scientific reports

Acta oncologica (Stockholm, Sweden)

Molecular & cellular oncology

Skånes universitetssjukhus Lund

Lund University Medical Faculty (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Skånes universitetssjukhus Lund

Sweden

Överläkare :: Obstetrik och gynekologi

Kliniken Essen-Mitte Evangelisches Huyssens-Stiftung Feb 01 2011 - Jan 31 2013

Germany

Oberärztin, Vsiiting Proferssor :: Gynecology and gynecologic oncology

Helsingborgs lasarett - Feb 28 2002

Sweden

Överläkare :: Obstetrik och Gynecologi

Education History

Lund University Medical Faculty Apr 10 1983 - Apr 29 1988

Sweden

PHD :: Its of medical cell research

Publications

Anna Norbeck, Mihaela Asp, Tobias Carlsson, Päivi Kannisto, Susanne Malander
Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer. Journal of multidisciplinary healthcare 16 (2023)
Anna Norbeck, Mihaela Asp, Tobias Carlsson, Päivi Kannisto, Susanne Malander
Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer. Journal of multidisciplinary healthcare 16 (2023)
Mihaela Asp, Ebba Peber, Päivi Kannisto, Anna Måsbäck, Susanne Malander
Ovarian tumor frozen section, a multidisciplinary affair. Acta oncologica (Stockholm, Sweden) 61 (7) (2022)
Maria Bååth, Sofia Westbom-Fremer, Laura Martin de la Fuente, Anna Ebbesson, Juliette Davis, Susanne Malander, Anna Måsbäck, Päivi Kannisto, Ingrid Hedenfalk
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery. Molecular & cellular oncology 7 (6) (2020)
Nicolai Skovbjerg Arildsen, Laura Martin de la Fuente, Anna Måsbäck, Susanne Malander, Ola Forslund, Päivi Kannisto, Ingrid Hedenfalk
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method. Scientific reports 9 (1) (2019)